Hidalga Technologies, Inc. noted in its June 2026 comments on CMS's Interoperability Standards and Prior Authorization for Drugs proposed rule (CMS-0062-P) that the Community Oncology Alliance supported expanding electronic prior authorization to drugs, including those under the medical benefit, and requiring payers to give specific reasons for denials.
Public source
Publisher name
Public post
Electronic prior authorization will only reduce administrative burden if the data behind it is complete, usable, and relevant to oncology care. In its June 2026 comments…
Company
Hidalga Technologies, Inc.
Administrative workflow optimization systems for community oncology.
- Industry
- Software Development
- Location
- Bentonville, US
- Company size
- 2–10 employees
About Hidalga Technologies, Inc.
Hidalga Technologies builds software to reduce the friction, delays, and administrative waste created by prior authorization in specialty care, starting with oncology. Today, specialty clinics lose hundreds of staff hours each month to portal logins, documentation rework, and payer follow-ups. These inefficiencies don’t just strain operations and finances, they delay treatment, exhaust clinic teams, and create uncertainty for patients who cannot afford to wait. hidalga automates the most burdensome parts of prior authorization. Our platform extracts structured clinical data from the EHR, assembles payer-specific forms and justification, and tracks each request in real time so teams know exactly what’s needed and what comes next. Clinics using hidalga reduce rework, lower avoidable denials, and move patients into treatment faster with greater predictability. hidalga is built to fit real clinic workflows, integrating with existing EHRs, payer processes, and compliance requirements without disruption. The platform validates data early, assembles payer-specific forms and justifications, and flags denial risk before submission to reduce rework and delays. A single, real-time view replaces portal hopping, while structured outputs support CMS and commercial payers across fax and portal workflows. The result is fewer denials and faster, more predictable paths to treatment, without adding staff or replacing core systems. Founded in the heartland of the U.S., Hidalga Technologies is conducting low-lift, risk-free pilots with rural oncology clinics. We are supported by NSF innovation funding, clinical advisors, and technologists focused on removing one of the most persistent bottlenecks in cancer care delivery. We help clinic teams reclaim time, reduce administrative strain, and keep care moving forward, so attention stays where it belongs: with patients. Want to reduce your clinic’s prior authorization burden? Let’s talk.
See moreLatest activity
Latest activity from Hidalga Technologies, Inc.
3 signals
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Optinosis
Optinosis published a whitepaper titled Leveraging Claims-Based Risk Stratification for Earlier Cancer Detection that explains how health plans can identify members at high risk for undiagnosed cancers.
Research & Knowledge
mTuitive
mTuitive's CMO Ken Dec explores why structured data is the foundation for more proactive quality improvement in oncology.
Research & Knowledge
McKesson Compile
McKesson Compile published a white paper exploring how alerts tied to claims events can help inform oncology care, outreach, and provider relevance.
Research & Knowledge
KairosHelix
KairosHelix published a case study on the rapid optimization of a KRAS-PDAC clinical trial design.
Research & Knowledge
Panakeia